A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

Acharyya, Swarnali, Oskarsson, Thordur, Vanharanta, Sakari, Malladi, Srinivas, Kim, Juliet, Morris, Patrick G., Manova-Todorova, Katia, Leversha, Margaret +5 more·2012·Cell

Cited by (1,000)

Items 301–400 of 1,000

  1. Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer
    Mojdeh Shakiba, David Arthur Tuveson · 2025 · Nature Immunology
  2. The epigenetic/noncoding origin of tumor dormancy
    Francesco Crea, Nur Ridzwan Nur Saidy, Colin C. Collins, Yuzhuo Z. Wang · 2015 · Trends in Molecular Medicine
  3. Tumor promoters: from chemicals to inflammatory proteins
    Hirota Fujiki, Eisaburo Sueoka, Masami Suganuma · 2013 · Journal of Cancer Research and Clinical Oncology
  4. Three-dimensional bio-printing: A new frontier in oncology research
    Nitin B. Charbe, Paul A. McCarron, Murtaza M. Tambuwala · 2017 · World Journal of Clinical Oncology
  5. Drug screening in Drosophila; why, when, and when not?
    Tin Tin Su · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
  6. Determinants of renal cell carcinoma invasion and metastatic competence
    Kangsan Kim, Qin-Bo Zhou, A. Christie, C. Stevens, Yuanqing Ma, Oreoluwa Onabolu, Suneetha Chintalapati, Tiffani McKenzie, V. Tcheuyap, Layton Woolford et al. · 2021 · Nature Communications
  7. Tumor-Associated Mast Cells in Thyroid Cancer
    Carla Visciano, Nella Prevete, Federica Liotti, Gianni Marone · 2015 · International Journal of Endocrinology
  8. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
    Jhih-Ying Chi, Yu‐Wei Hsiao, Chien‐Feng Li, Yu-Chih Lo, Zu‐Yau Lin, Jhen‐Yi Hong, Yang-Ming Liu, Xiu Han, Shao‐Ming Wang, Ben‐Kuen Chen et al. · 2015 · Oncotarget
  9. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
    Anusha Pusuluri, Debra Wu, Samir Mitragotri · 2019 · Journal of Controlled Release
  10. Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
    Lei Yu, Jian Zhang, Yunfeng Li · 2022 · Frontiers in Immunology
  11. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver
    Yu Zhang, Celestia Davis, James C. Ryan, Cory Janney, Maria Marjorette O. Peña · 2013 · Clinical & Experimental Metastasis
  12. Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression
    H. C. Gusky, Jonathan D Diedrich, O. MacDougald, Izabela Podgorski · 2016 · Obesity Reviews
  13. Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy
    Serena Zilio, Paolo Serafini · 2016 · Vaccines
  14. Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
    Xiaotong Li, Sarah E. Warren, Vasiliki Pelekanou, Vikram B. Wali, Alessandra Cesano, Mingdong Liu, Patrick J. Danaher, Nathane Elliott, Zeina A. Nahleh, Daniel F. Hayes et al. · 2019 · Journal for ImmunoTherapy of Cancer
  15. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
    Alafate Wahafu, Xiaodong Li, Jie Zuo, Hua Zhang, Jianyang Xiang, Wei Wu, Wanfu Xie, Xiaobin Bai, Maode Wang, Jia Wang · 2020 · CNS Neuroscience & Therapeutics
  16. Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics
    Saumya Srivastava, Atish Ranjan Mohanty, Arin Nam, Sharad S. Singhal, Ravi Salgia · 2022 · Seminars in Cancer Biology
  17. Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
    Jie Xu, Cai-feng Yue, Wei-hua Zhou, Yuan Qian, Yan Zhang, Shao-wu Wang, An-wen Liu, Quentin Liu · 2014 · Journal of Translational Medicine
  18. Metastatic growth instructed by neutrophil-derived transferrin
    Wei Ping Liang, Qin Li, Napoleone Ferrara · 2018 · Proceedings of the National Academy of Sciences
  19. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT‐11‐resistant LoVo colon cancer cells via Gαi‐2 and Gαq/11
    Ming‐Cheng Chen, Rathinasamy Baskaran, Nien‐Hung Lee, Hsi-Hsien Hsu, Tsung‐Jung Ho, Chuan‐Chou Tu, Yueh‐Min Lin, Vijaya Padma Viswanadha, Wei‐Wen Kuo, Chih‐Yang Huang · 2018 · Journal of Cellular Physiology
  20. Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein ofHelicobacter pylori
    Tatsuro Watanabe, Atsushi Takahashi, Kaori Suzuki, Miki Kurusu, Kensei Yamaguchi, Hirota Fujiki, Masami Suganuma · 2013 · International Journal of Cancer
  21. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells
    Wenying Zhang, Qiongwei Wu, Chao Wang, Longtao Yang, Ping Liu, Chengbin Ma · 2018 · Molecular and Cellular Biochemistry
  22. USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade
    Zhaojuan Yang, Guiqin Xu, Boshi Wang, Yun Liu, Li Zhang, Tiantian Jing, Ming Tang, Xiaoli Xu, Kun Jiao, Lvzhu Xiang et al. · 2021 · Nature Communications
  23. Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation
    Ze-Yi Zheng, Lin Hai Tian, Wen Bu, Cheng Fan, Xia Gao, Hai Wang, Yi‐Hua Liao, Yi Li, Michael T. Lewis, Dean P. Edwards et al. · 2015 · Cell Reports
  24. Molecular Pathways: Tumor-Derived Microvesicles and Their Interactions with Immune CellsIn Vivo
    Ferdinando Pucci, Mikaël J. Pittet · 2013 · Clinical Cancer Research
  25. Roles of DNA repair enzyme OGG1 in innate immunity and its significance for lung cancer
    Spiros Vlahopoulos, Maria Adamaki, Nikolas Khoury, Vassilis C. Zoumpourlis, Istvan R. Boldogh · 2018 · Pharmacology & Therapeutics
  26. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
    Dhruba Kadel, Yu Zhang, Haoran Sun, Yue Zhao, Qiongzhu Dong, Lun‐Xiu Qin · 2019 · Cell Biology and Toxicology
  27. Macrophages-aPKCɩ-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma
    Tao Yang, Zhengdong Deng, Lei Xu, Xiangyu Li, Yang Tan, Yawei Qian, Yun Lü, Li Tian, Wei Yao, Jianming Wang · 2022 · Journal of Experimental & Clinical Cancer Research
  28. Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads
    Fabrizio Marcucci, Matteo Bellone, Carmelo Antonio Caserta, Angelo Corti · 2013 · International Journal of Cancer
  29. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression
    Carrie A. Duckworth, Linxue Zhang, Steven Lewis Carroll, Stephen P. Ethier, Hiu Wing Cheung · 2015 · Oncogene
  30. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling
    Yifeng Zheng, Neng Wang, Shengqi Wang, Bowen Yang, Honglin Situ, Linda L. D. Zhong, Yi Heng Lin, Zhiyu Wang · 2020 · Cell Communication and Signaling
  31. Nuclear pore protein NUP210 depletion suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response
    Ruhul Amin, Anjali Shukla, Jacqueline Jufen Zhu, Sohyoung Kim, Ping Wang, Simon Zhongyuan Tian, Andy D. Tran, Debasish Paul, Steven D. Cappell, Sandra Sczerba Burkett et al. · 2021 · Nature Communications
  32. Chemoproteomic mapping of the glycolytic targetome in cancer cells
    Yang Tian, Ning Wan, Hanqing Zhang, Chang Shao, Ming Ding, Qiuyu Bao, Hai Hu, Huiyong Sun, Chenguang Liu, Kun Zhou et al. · 2023 · Nature Chemical Biology
  33. CXCR2-Driven Ovarian Cancer Progression Involves Upregulation of Proinflammatory Chemokines by Potentiating NF-κB Activation via EGFR-Transactivated Akt Signaling
    Yuan-Lin Dong, Syeda M. Kabir, Eun-Sook Lee, Deok‐Soo Son · 2013 · PLoS ONE
  34. S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy
    W.T. Kim, John Kim, Chunri Yan, Pildu Jeong, Song‐Yi Choi, O. J. Lee, Y.B. Chae, Seok Joong Yun, S.C. Lee, W.J. Kim · 2014 · Annals of Oncology
  35. Roles of S100 family members in drug resistance in tumors: Status and prospects
    Xin Hua, Hongming Zhang, Jinfang Jia, Shanshan Chen, Yue Sun, Xiaoli Zhu · 2020 · Biomedicine & Pharmacotherapy
  36. Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment
    Jingyi Chen, You-Syuan Lai, Pei‐Yi Chu, Shih‐Hsuan Chan, Lu‐Hai Wang, Wen‐Chun Hung · 2019 · Cancers
  37. Single-cell transcriptome analysis reveals cellular heterogeneity in the ascending aortas of normal and high-fat diet-fed mice
    Hao Kan, Ka Zhang, Aiqin Mao, Li Geng, Mengru Gao, Lei Feng, Qingjun You, Xin Ma · 2021 · Experimental & Molecular Medicine
  38. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer
    Takanori Kitamura, Jeffrey W. Pollard · 2015 · Pharmacological Research
  39. Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer
    Yuji Takeyama, Minoru Kato, Satoshi Tamada, Yukari Azuma, Yasuomi Shimizu, Taro Iguchi, Takeshi Yamasaki, Min Gi, Hideki Wanibuchi, Tatsuya Nakatani · 2020 · Cancer Letters
  40. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
    Angela M. Araujo, Andrea Abaurrea, Peio Azcoaga, Joanna I. López-Velazco, Sara Manzano, Javier Rodríguez, Ricardo Rezola, Leire Egia‐Mendikute, Fátima Valdés‐Mora, Juana María Flores et al. · 2022 · Journal of Clinical Investigation
  41. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells
    Hao Yu, Yudong Liu, Braden C. McFarland, Jessy S. Deshane, Douglas R. Hurst, Selvarangan Ponnazhagan, Etty N. Benveniste, Hongwei Qin · 2015 · Cancer Immunology Research
  42. Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis
    Neng Wang, Yifeng Zheng, Jiangyong Gu, Youli Cai, Shengqi Wang, Fengxue Zhang, Jianping Chen, Honglin Situ, Yi Heng Lin, Zhiyu Wang · 2017 · Scientific Reports
  43. Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer
    Lin Zhou, Le Xu, Lingli Chen, Qiang Fu, Zheng Liu, Yuan Chang, Zongming Lin, Jiejie Xu · 2017 · OncoImmunology
  44. Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis
    Patricia Fernández‐Nogueira, Gemma Fuster, Álvaro Gutiérrez-Uzquiza, Pere Gascón, Neus Carbó, Paloma Bragado · 2021 · Cancers
  45. HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models
    Simone C. Stone, R. A. M. Rossetti, Aleida Maria Lima, Ana Paula Lepique · 2014 · Immunity Inflammation and Disease
  46. The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116
    Daiva Dabkevičienė, Violeta Jonušienė, Vilmantė Žitkutė, Eglė Žalytė, Pranas Grigaitis, Vida Kirvelienė, Aušra Sasnauskienė · 2015 · Medical Oncology
  47. Somatic mutations in leukocytes infiltrating primary breast cancers
    Maria Kleppe, Elizabeth Anne Comen, Hannah Yong Wen, Lennart Bastian, Brian Blum, Franck T Rapaport, Matthew Keller, Zvika Granot, Nicolas Socci, Agnes J. Viale et al. · 2015 · npj Breast Cancer
  48. Energy metabolism in cancer stem cells
    Xuan Zhu, Huihui Chen, Chenyi Gao, Xinxin Zhang, Jingxin Jiang, Yi Zhang, Jun Fang, Feng Zhao, Zhigang Chen · 2020 · World Journal of Stem Cells
  49. NF-κB in Gastric Cancer Development and Therapy
    Supattra Chaithongyot, Phatcharida Jantaree, Olga V. Sokolova, Michael Naumann · 2021 · Biomedicines
  50. Immunological nanomaterials to combat cancer metastasis
    Yuanbo Pan, Junjie Cheng, Yang Zhu, Jianmin Zhang, Wenpei Fan, Xiaoyuan Shawn Chen · 2024 · Chemical Society Reviews
  51. The mutant p53 mouse as a pre-clinical model
    James G. Jackson, Guillermina Lozano · 2013 · Oncogene
  52. Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment
    Dhanya K. Nambiar, Vignesh Viswanathan, Hongbin Cao, Weiruo Zhang, Li Guan, Manish Chamoli, Brittany Holmes, Christina S. Kong, Rachel Hildebrand, Amanda Jeanette Koong et al. · 2023 · Cancer Research
  53. Neutrophils in cancer: from biology to therapy
    Leo Koenderman, Nienke Vrisekoop · 2024 · Cellular and Molecular Immunology
  54. Inflammation‐induced S100A8 activates I d3 and promotes colorectal tumorigenesis
    Xuemei Zhang, Feiyan Ai, Xiayu Li, Xiaoling She, Nan Li, Anliu Tang, Zailong Qin, Qiurong Ye, Li Tian, Guiyuan Li et al. · 2015 · International Journal of Cancer
  55. Microenvironment in metastasis: roadblocks and supportive niches
    Maren Pein, Thórdur Óskarsson · 2015 · American Journal of Physiology-Cell Physiology
  56. Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
    Zhiqiang Ye, Shengli Yin, Zhongzhen Su, Mingjun Bai, Haibo Zhang, Ziqing Hei, Songwang Cai · 2016 · Oncotarget
  57. Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment
    Kelly A. Hogan, Dong Seong Cho, Paige C. Arneson‐Wissink, Adrienne Samani, Patrick A. Palines, Yanan Yang, Jason D. Doles · 2017 · Cytokine
  58. Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
    Jun Ding, Kangdi Xu, Jie Zhang, Bingyi Lin, Yubo Wang, Shengyong Yin, Haiyang Xie, Lin Zhou, Shusen Zheng · 2018 · BMB Reports
  59. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
    Tamir Baram, Linor Rubinstein-Achiasaf, Hagar Ben-Yaakov, Adit Ben‐Baruch · 2021 · Frontiers in Oncology
  60. Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation
    Sowmya Ramachandran, Amit Kumar Verma, Kapil Dev, Yamini Goyal, Deepti Bhatt, Mohammed A. Alsahli, Arshad Husain Rahmani, Ahmad Almatroudi, Saleh A. Almatroodi, Faris Alrumaihi et al. · 2021 · Oxidative Medicine and Cellular Longevity
  61. WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells
    Wen G. Jiang, David K. Crossman, Elizabeth Mitchell, Philip Sohn, Michael R. Crowley, Rosa A. Serra · 2013 · PLoS ONE
  62. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells
    JiHoon Kang, Wanyeon Kim, TaeWoo Kwon, HyeSook Youn, Joong‐Sun Kim, BuHyun Youn · 2016 · Oncotarget
  63. The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction
    Eva Koellensperger, Lilly-Claire Bonnert, Inka Zoernig, Frederik Marmé, Stefanie Sandmann, Günter Germann, Felix Gramley, Uwe Leimer · 2017 · Stem Cell Research & Therapy
  64. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
    Yongchao Li, Tinghui Wu, Shujuan Gong, Hangzheng Zhou, Lufei Yu, Meiyan Liang, Ruijun Shi, Zhen-Hui Wu, Jinpei Zhang, Shuwei Li · 2021 · Frontiers in Oncology
  65. Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells
    Riesa M. Burnett, Kelly E. Craven, Purna Krishnamurthy, Chirayu Pankaj Goswami, Sunil Badve, Peter Anthony Crooks, William P. Mathews, Poornima Bhat‐Nakshatri, Harikrishna Nakshatri · 2015 · Oncotarget
  66. Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer
    Ken Katono, Yuichi Sato, Shi‐Xu Jiang, Makoto Kobayashi, Ryo Nagashio, Shinichiro Ryuge, Eriko Fukuda, Naoki Goshima, Yukitoshi Satoh, Makoto Saegusa et al. · 2015 · PLoS ONE
  67. Cancer-Associated Oxidoreductase ERO1-α Drives the Production of Tumor-Promoting Myeloid-Derived Suppressor Cells via Oxidative Protein Folding
    Tsutomu Tanaka, Toshimitsu Kajiwara, Toshihiko Torigoe, Yoshiharu Okamoto, Noriyuki Sato, Yasuaki Tamura · 2015 · The Journal of Immunology
  68. Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment
    María Belén Giorello, Francisco Raúl Borzone, Vivian Labovsky, Flavia Piccioni, Norma Alejandra Chasseing · 2021 · Journal of Mammary Gland Biology and Neoplasia
  69. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer
    Qi Yang, Xing Li, Han Chen, Yingjiao Cao, Qiang Xiao, Yun He, Jianyang Wei, Jie Zhou · 2017 · Oncogene
  70. Cytokine-mediated therapeutic resistance in breast cancer
    Chunli Tan, Weizi Hu, Yunjie He, Yanyan Zhang, Guangqin Zhang, Yong Xu, Jinhai Tang · 2018 · Cytokine
  71. An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer
    Amaresh Mishra, Kamrul Hassan Suman, Nisha Nair, Jaseela Majeed, Vishwas Tripathi · 2021 · Molecular Biology Reports
  72. Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
    Kate Lynette Mahon, H-M Lin, Lesley E. Castillo, B Y Lee, Michelle Lee-Ng, Mark D. Chatfield, Karen Chiam, Samuel N. Breit, David Alexander Brown, Mark P. Molloy et al. · 2015 · British Journal of Cancer
  73. An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer
    Yael Raz, Neta Erez · 2013 · Experimental Cell Research
  74. CXCR2: a target for pancreatic cancer treatment?
    Kathleen M. Hertzer, Graham W. Donald, Oscar Joe Hines · 2013 · Expert Opinion on Therapeutic Targets
  75. CXCR2 Macromolecular Complex in Pancreatic Cancer: A Potential Therapeutic Target in Tumor Growth
    Shuo Wang, Yanning Wu, Yuning Hou, Xiaoqing Guan, Marcello P. Castelvetere, Jacob J. Oblak, Sanjeev Banerjee, Theresa Marie Filtz, Fazlul H. Sarkar, Xuequn Chen et al. · 2013 · Translational Oncology
  76. Cancer-Associated Muscle Wasting—Candidate Mechanisms and Molecular Pathways
    Victoria Armstrong, Liam W. Fitzgerald, Oliver F. Bathe · 2020 · International Journal of Molecular Sciences
  77. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
    Sugandha Saxena, Rakesh K. Singh · 2021 · Cancer and Metastasis Reviews
  78. Cancer-associated fibroblasts: tumor defenders in radiation therapy
    Yalin Zhang, Na Lv, Manshi Li, Ming Liu, Chunli Wu · 2023 · Cell Death and Disease
  79. Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties
    Ingrid J. Bettum, Kotryna Vasiliauskaite, Vigdis Nygaard, Trevor Clancy, Solveig Pettersen, Ellen M. Tenstad, Gunhild Mari Mælandsmo, Lina Prasmickaite · 2013 · Cancer Letters
  80. Pleiotropic effects of cancer cells’ secreted factors on human stromal (mesenchymal) stem cells
    Mashael Al-Toub, Abdulaziz Almusa, Mohammed Almajed, May Salem Al-Nbaheen, Moustapha S Kassem, Abdullah M. Aldahmash, Nehad M. Alajez · 2013 · Stem Cell Research & Therapy
  81. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer
    Mitsuo Yokota, Hiroshi Katoh, Hiroshi Nishimiya, Mariko Kikuchi, Yoshimasa Kosaka, Norihiko Sengoku, Masahiko Watanabe, Keishi Yamashita · 2019 · Journal of Surgical Research
  82. Chronic Pancreatitis and the Development of Pancreatic Cancer
    Hemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Anil Mishra · 2020 · Endocrine Metabolic & Immune Disorders - Drug Targets
  83. Neutrophils’ dual role in cancer: from tumor progression to immunotherapeutic potential
    Gujie Wu, Binyang Pan, Haochun Shi, Yanjun Yi, Xiaobin Zheng, Huiyun Ma, Mengnan Zhao, Zhenshan Zhang, Lin Cheng, Yiwei Huang et al. · 2024 · International Immunopharmacology
  84. Tumor microenvironment: Nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy
    Hongyang Yu, Jinyang Li, Shiyin Peng, Qin Liu, Dongfeng Chen, Zongsheng He, Junyu Xiang, Bin Wang · 2024 · Cancer Letters
  85. Myeloid-derived cells are key targets of tumor immunotherapy
    José Medina‐Echeverz, Fernando Aranda, Pedro Berraondo · 2014 · OncoImmunology
  86. Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages
    Don-Hong Wang, Hyun‐Sung Lee, David K. Yoon, Gerald J. Berry, Thomas M. Wheeler, David J. Sugarbaker, Farrah Kheradmand, Edgar G. Engleman, Bryan M. Burt · 2016 · Clinical Cancer Research
  87. Neutrophils: Homing in on the myeloid mechanisms of metastasis
    Joshua D.G. Leach, Jennifer P. Morton, Owen James Sansom · 2017 · Molecular Immunology
  88. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress‐induced depression in mice
    Huihui Chai, Xiao‐Chun Fu, Liang Ma, Haitao Sun, G Chen, Min‐Ying Song, Weixuan Chen, Yong‐Sheng Chen, Min‐Xuan Tan, Yan‐Wu Guo et al. · 2019 · The FASEB Journal
  89. Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence
    Andrea Walens, Jiaxing Lin, Jeffrey S. Damrauer, Brock J. McKinney, Ryan Lupo, Rachel Newcomb, Douglas B. Fox, Nathaniel W. Mabe, Jeremy S. Gresham, Zhecheng Sheng et al. · 2020 · Nature Communications
  90. Glycogen Synthase Kinase 3β Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
    Yuri Chikano, Takahiro Domoto, Takuya Furuta, Hemragul Sabit, Ayako Kitano-Tamura, Ilya V. Pyko, Takahisa Takino, Yoshimichi Sai, Yutaka Hayashi, Hiroshi Sato et al. · 2014 · Molecular Cancer Therapeutics
  91. Immunosuppressive cell death in cancer
    Jiajie Hou, Tim F. Greten, Qiang Xia · 2017 · Nature reviews. Immunology
  92. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways
    Kohei Tanigawa, Shuichi Tsukamoto, Yu‐ichiro Koma, Yu Kitamura, Satoshi Urakami, Masaki Shimizu, Masataka Fujikawa, Takayuki Kodama, Mari Nishio, Manabu Shigeoka et al. · 2021 · American Journal Of Pathology
  93. The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer.
    Hyeok-Won An, Sang Hyeok Seok, Jong-Wan Kwon, A. Choudhury, Jeong-Seop Oh, D. Voon, Dae-Yong Kim, Jun Won Park · 2022 · Cell Reports
  94. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer
    Jan Korbecki, Mateusz Bosiacki, Katarzyna Barczak, Ryta Łagocka, Agnieszka Brodowska, Dariusz Chlubek, Irena Baranowska‐Bosiacka · 2023 · International Journal of Molecular Sciences
  95. Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis
    Kelly Elizabeth Johnson, Jodi A. Forward, Mason D. Tippy, Julia R. Ceglowski, Saleh H. El-Husayni, Rajesh Kulenthirarajan, Kellie R. Machlus, Erica L. Mayer, Joseph E. Italiano, Elisabeth M. Battinelli · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  96. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis
    Linlin Ren, Tingting Yan, Chaoqin Shen, Jia‐Yin Tang, Xuan Kong, Yingchao Wang, Jinxian Chen, Qiang Liu, Jie He, Ming Zhong et al. · 2018 · Cell Death and Disease
  97. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins
    Mohd Wasim Nasser, Mohamad Elbaz, Dinesh Kumar Ahirwar, Ramesh Kumar Ganju · 2015 · Cancer Letters
  98. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study
    Jae‐Keun Cho, Myoung Woo Kim, Ick Soo Choi, Uk Yeol Moon, Min‐Ji Kim, Insuk Sohn, Seonwoo Kim, Han‐Sin Jeong · 2018 · BMC Cancer
  99. Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release
    Wen Liu, Ting Fan, Manru Li, Guohui Zhang, Wenjie Guo, Xiaoling Yang, Chunhong Jiang, Xiang Li, Xiangyu Xu, Tang Anshu et al. · 2020 · International Immunopharmacology
  100. The MNK1/2–eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer
    Qianyu Guo, Margarita Bartish, Christophe Gonçalves, Fan Huang, Julian Smith-Voudouris, Sai Sakktee Krisna, Samuel E.J. Preston, Audrey Émond, Vivian Z. Li, Claudia U. Duerr et al. · 2021 · Cancer Research